Tag
OpenAI, PerturbAI, and Scripps Research used thousands of GPT-Rosalind-powered AI agents to analyze a whole-brain CRISPR atlas of millions of mouse brain cells in just 32 minutes, uncovering new leads on Alzheimer's and Parkinson's disease biology through distributed biological reasoning.
OpenAI announced the Rosalind Academic Plan, offering eligible academic labs up to 30 free Business Standard seats for 12 months with access to GPT-Rosalind, a specialized life sciences model, and the Rosalind Workbench for scientific research.
OpenAI introduces an updated GPT-Rosalind model purpose-built for life sciences research, with improved performance in medicinal chemistry, genomics, and drug-discovery workflows, and new benchmarks like LifeSciBench and MedChemBench.
OpenAI announces Rosalind Biodefense, a program to provide trusted developers and U.S. government partners with advanced AI tools for biodefense and pandemic preparedness, building on earlier GPT-Rosalind capabilities and safety frameworks.
OpenAI releases GPT-Rosalind, a specialized life sciences model optimized for protein reasoning, chemical analysis, genomics, and scientific workflows.
OpenAI introduces GPT-Rosalind, a frontier reasoning model specifically designed to support research in biology, drug discovery, and translational medicine.